The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Arsenic trioxide (Brand name: Trisenox)
- Manufactured by
Cell Therapeutics, Inc.
FDA-approved indication: For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation.
National Library of Medicine Drug Information PortalMedline Plus Health Information